The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national ‘Happy Breathing’ Programme
Open Access
- 15 July 2024
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 74, 102597
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82090011)
- Chinese Academy of Meteorological Sciences (2021-I2M-1-049)
- Alexander von Humboldt-Stiftung
- HORIZON EUROPE Framework Programme (101086139-PoPMeD-SuSDeV)
- HORIZON EUROPE Framework Programme (HORIZON-MSCA-2021-SE-01)
This publication has 59 references indexed in Scilit:
- Prevalence and Treatment of Diabetes in China, 2013-2018JAMA, 2021
- Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016JAMA Internal Medicine, 2019
- Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studyThe Lancet, 2018
- Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)The Lancet, 2017
- Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population studyThe Lancet, 2011
- Internal migration and health in ChinaThe Lancet, 2008
- Global burden of COPD: risk factors, prevalence, and future trendsThe Lancet, 2007
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- Prevalence of nutritional depletion in a large out-patient population of patients with COPDRespiratory Medicine, 2006
- Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyThe Lancet, 2005